This move is archived. Current quotes and coverage live on the stock page.
Get MDNA alerts:
Medicenna Therapeutics Corp's stock increased by 3.61% in the last trading session, showing positive investor sentiment.
On the TSX, Medicenna Therapeutics Corp (MDNA.TO) closed at CA$0.43. This rise comes as the company makes strides in its funding strategies and market positioning, attracting investors interested in promising biotech opportunities.
Advertisement
Medicenna Therapeutics Corp
MDNA.TO
MDNA.TO
Medicenna Therapeutics Corp
WealthAwesomeMarket cap
$43.38M
52W high
$1.97
52W low
$0.34
1W change
+2.17%
Beta
1.96
Analyst Price Targets
Based on analyst covering MDNA
Wall Street analysts forecast MDNA stock price to rise 580.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.20
+580.9% Upside
Current Price
C$0.47
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDNA's historical volatility
30-Day Vol
61.7%
Annualized
90-Day Vol
65.8%
Annualized
Trend (90d)
+47.2%
Annualized drift
90d Mean
C$0.56
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.50 | C$0.40 – C$0.62 |
| 60 trading days | C$0.53 | C$0.39 – C$0.71 |
| 90 trading days | C$0.56 | C$0.38 – C$0.80 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The uptick in Medicenna's stock price indicates growing confidence among investors, especially after the company's recent public offerings aimed at strengthening its financial position.
Medicenna's Stock Up 3.61% in One Day
Medicenna's market cap is now CA$34.6 million, reflecting optimism from investors driven by recent funding activities.
Bull case
Medicenna successfully completed a public offering that raised about $4.44 million by issuing nearly 8.88 million units. This new capital will help the company boost its research and development efforts, which could lead to important breakthroughs in its clinical trials.
Bear case
Despite the positive movement, the absence of immediate news or significant product developments could create volatility. Investors might be cautious about whether this upward trend can be sustained.
Advertisement
Recent Public Offering Boosts Investor Confidence
Medicenna recently wrapped up a public offering, raising around $4.44 million. This funding is expected to support the company's ongoing research and clinical trials, which are crucial for its future growth.
Market Response and Future Outlook
The positive response to Medicenna's stock reflects a broader trend of investor interest in biotech firms actively seeking funding to advance their projects. While the stock's rise is encouraging, investors should stay alert for the company's upcoming announcements and clinical trial results that could impact its stock performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
